日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Maintenance therapy after first-line therapy for ovarian cancer: Quantitative effectiveness

卵巢癌一线治疗后的维持治疗:定量疗效

Campos, Susana M; DiSilvestro, Jessica; Blank, Stephanie V

Comparative Modeling of Recent and Projected Trends in the Incidence and Mortality of Uterine Cancer

子宫癌发病率和死亡率近期及预测趋势的比较模型

Rouse, Kevin J; Hazelton, William D; Frotscher, Axel; Chen, Ling; Prest, Matthew T; Ferris, Jennifer S; Xu, Xiao; Melamed, Alexander; Hur, Chin; Heckman-Stoddard, Brandy M; Samimi, Goli; Bickell, Nina A; Layne, Tracy M; Blank, Stephanie V; Elkin, Elena B; Myers, Evan R; Havrilesky, Laura J; Kong, Chung Yin; Wright, Jason D

Endometrial Mixed and Mixed-Feature Carcinomas: Small Cohort Clinicopathologic and Molecular Studies

子宫内膜混合型和混合特征型癌:小型队列临床病理学和分子研究

Bhardwaj, Swati; Saleh, Mona; Kinoshita, Yayoi; Brody, Rachel; Lukatskaya, Olga; Blank, Stephanie V; Baskovich, Brett; Kalir, Tamara

Neoadjuvant Chemotherapy Versus Primary Cytoreductive Surgery for Metastatic Endometrial Cancer

转移性子宫内膜癌的新辅助化疗与原发性细胞减灭术的比较

Sassine, Dib; Huang, Yongmei; Hur, Chin; Elkin, Elena B; Ferris, Jennifer S; Melamed, Alex; Kong, Chung Yin; Myers, Evan R; Bickell, Nina A; Hazelton, William D; Layne, Tracy M; Heckman-Stoddard, Brandy; Samimi, Goli; Havrilesky, Laura J; Blank, Stephanie V; Xu, Xiao; Wright, Jason D

Plain language summary of results from the DUO-E study: durvalumab given with or without olaparib in patients with advanced endometrial cancer

DUO-E 研究结果的简明语言总结:度伐利尤单抗联合或不联合奥拉帕尼治疗晚期子宫内膜癌患者

Westin, Shannon N; Moore, Kathleen; Chon, Hye Sook; Lee, Jung-Yun; Thomes Pepin, Jessica; Sundborg, Michael; Shai, Ayelet; de la Garza, Joseph; Nishio, Shin; Gold, Michael A; Wang, Ke; McIntyre, Kristi; Tillmanns, Todd D; Blank, Stephanie V; Liu, Ji-Hong; McCollum, Michael; Contreras Mejia, Fernando; Nishikawa, Tadaaki; Pennington, Kathryn; Novak, Zoltan; De Melou, Andreia Cristina; Sehouli, Jalid; Klasa-Mazurkiewicz, Dagmara; Papadimitriou, Christos; Gil-Martin, Marta; Brasiuniene, Birute; Donnelly, Conor; Liu, Xiaochun; Nieuwenhuysen, Els Van

Tisotumab vedotin-associated Stevens-Johnson syndrome in a patient with recurrent vulvar cancer: Vulnerability and antibody drug conjugate toxicity considerations

复发性外阴癌患者接受Tisotumab vedotin治疗后出现Stevens-Johnson综合征:易感性和抗体药物偶联物毒性考量

Chess, Isabel; Mercier, Ann Marie; Gross, Sarah; Blank, Stephanie V; Hayes, Monica Prasad

Survival After Fertility-Preserving Hormonal Therapy vs Hysterectomy for Early-Stage Endometrial Cancer

早期子宫内膜癌患者接受保留生育功能的激素治疗与子宫切除术后的生存率比较

Suzuki, Yukio; Huang, Yongmei; Xu, Xiao; Ferris, Jennifer S; Elkin, Elena B; Kong, Chung Yin; Myers, Evan R; Saji, Haruya; Miyagi, Etsuko; Havrilesky, Laura J; Blank, Stephanie V; Hershman, Dawn L; Wright, Jason D

Unlocking the therapeutic potential of rigosertib as a selective therapy for ovarian cancer.

释放利戈塞替尼作为卵巢癌选择性疗法的治疗潜力

Nath Shalini, Claridge Sally, Granados Genesis Lara, Al Assaad Majd, Park Eric, Cavallo Julie-Ann, Nuwere Ufuoma, Ackon Maame Esi, De Boni Lamberto, Baker Stacey, Reddy E Premkumar, Blank Stephanie V, Elemento Olivier, Brody Rachel, Hopkins Benjamin D

Optimization of Timing for Risk-Reducing Salpingectomy and Oophorectomy

优化降低风险的输卵管切除术和卵巢切除术的时机

Pennington, Kathryn P; Pugh, Stephanie L; Huh, Warner; Walker, Joan L; Jewell, Elizabeth; Havrilesky, Laura J; Carter, Jeanne; Muller, Carolyn Y; Drapkin, Ronny; Lankes, Heather A; Castellano, Tara; Zamorano, Abigail S; Blank, Stephanie V; Kachnic, Lisa A

Ultrasound-based versus immediate biopsy-based management of postmenopausal bleeding in non-Hispanic Black and non-Hispanic White individuals

超声引导与立即活检治疗非西班牙裔黑人和非西班牙裔白人绝经后出血的比较

Nolin, Angela C; Atkins, Sage L; Myers, Evan R; Wentzensen, Nicolas; Clarke, Megan A; Blank, Stephanie V; Wright, Jason D; Doll, Kemi M; Havrilesky, Laura J